Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial.

@article{Firooz2006ImiquimodIC,
  title={Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial.},
  author={Alireza Firooz and Ali Khamesipour and Mohammad Hossein Ghoorchi and Mansour Nassiri-Kashani and Seyed Ebrahim Eskandari and Alireza Khatami and Badakhshan Hooshmand and Farzam Gorouhi and Mehdi Rashighi-Firoozabadi and Yahya Dowlati},
  journal={Archives of dermatology},
  year={2006},
  volume={142 12},
  pages={1575-9}
}
OBJECTIVE To determine the efficacy and safety of imiquimod in combination with meglumine antimoniate in treating cutaneous leishmaniasis. DESIGN Prospective, randomized, assessor-blind, parallel-design, placebo-controlled trial. SETTING Two primary care health clinics. PATIENTS One hundred nineteen patients (59 patients in the imiquimod group and 60… CONTINUE READING